Who are ETHER's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Plegisol In Plastic Container, Plegisol In Plastic Container, Sodium Chloride 23.4%, High Dose PF-07328948, MET233 and MET097, Bacteriostatic Water For Injection In Plastic Container.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ether.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

ETHER — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ETHER (ETHER) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Standardized Chemical Allergen [EPC]. Area: Gastroenterology.

marketed Standardized Chemical Allergen [EPC] Not specified Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

ETHER (ETHER).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
ETHER TARGET	ETHER		marketed	Standardized Chemical Allergen [EPC]	Not specified
Plegisol In Plastic Container	Sodium Chloride	Baxter	marketed	Electrolyte solution	Not specified	1965-01-01
Plegisol In Plastic Container	Sodium Chloride	Baxter	marketed	Electrolyte solution	Not specified	1965-01-01
Sodium Chloride 23.4%	Sodium Chloride	Pfizer Inc.	marketed	Electrolyte irrigation solution	Not specified
High Dose PF-07328948	high-dose-pf-07328948	Pfizer	marketed	Not specified	Not specified
MET233 and MET097	met233-and-met097	Pfizer	marketed	Not specified	Not specified
Bacteriostatic Water For Injection In Plastic Container	Sterile Water For Injection	Pfizer Inc.	marketed	Parenteral drug product	Not specified

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Standardized Chemical Allergen [EPC] class)

· 7 drugs in this class
Deseret Biologicals, Inc. · 2 drugs in this class
Donat R. Spahn · 1 drug in this class
Dr. Laurence Klotz · 1 drug in this class
Marjan Industria e Comercio ltda · 1 drug in this class
Millet Roux · 1 drug in this class
Nantes University Hospital · 1 drug in this class
Nutritional Specialties, Inc. · 1 drug in this class
Pfizer · 1 drug in this class
Tablicaps · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ETHER — Competitive Intelligence Brief. https://druglandscape.com/ci/ether. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing